In a randomized phase II trial, researchers assessed whether perioperative chemotherapy improved overall survival for patients with pancreatic cancer who underwent surgery.
In a randomized phase II trial, researchers assessed whether perioperative chemotherapy improved overall survival for patients with pancreatic cancer who underwent surgery.